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The minimal inhibitory concentrations of penicillin and six other antibiotics
were determined for 66 oral black-pigmented Bacteroides isolates by using the
National Committee for Clinical Laboratory Standards proposed standard agar
dilution technique. These results plus iodometric determination of j-lactamase
activity showed that oral isolates of black-pigmented Bacteroides are remaining
relatively susceptible to commonly used antibiotics.
The purpose of our study was to determine the
The black-pigmented Bacteroides species
(BPB) (B. melaninogenicus and B. asaccharoly- antibiotic susceptibility of oral isolates of BPB
ticus) are commonly found as normal flora in the from healthy mouths. These data will aid in
human intestinal and reproductive tracts and in establishing a protocol for therapy since these
the oral cavity (3). Their incidence within the isolates are constituents of the normal oral flora
oral cavity seems to increase with the eruption and it is this normal flora which serves as the
of permanent teeth (13), and, along with other source of pulpal, periapical, and periodontal
normal oral flora, they are characteristically infections.
A total of 66 BPB isolates were obtained from
involved in endodontic as well as periodontic
infections (4, 13).
specimens of subgingival plaque collected from
The significance of B. melaninogenicus in freshman dental students (n = 9) and patients
endodontic infections was first shown in 1976 by seen in the dental hygiene clinic (n = 53) at the
Sundqvist, who studied the microbial flora of Marquette University School of Dentistry, Milteeth with pulpal necrosis (G. Sundqvist, Umea waukee, Wis., as well as from pulps of patients
University Odontological Dissertation, Umea, undergoing endodontic therapy in private pracSweden, 1976). He found that only those teeth tice (n = 4). Since the results did not reveal any
with periapical destruction contained bacteria significant differences in the antibiotic susceptiand that symptoms of acute periapical inflamma- bility of these isolates, no distinction between
tion were present only in teeth containing B. the groups is made below.
melaninogenicus as part of the microbial flora.
Plaque specimens were collected into reduced
Griffee et al. in 1980 demonstrated a similar thioglycollate medium without indicator (Difco
relationship between periapical symptoms and Laboratories, Detroit, Mich.) and dispersed by
the presence of B. melaninogenicus (4).
shaking with a glass bead. Each broth was
Penicillin has traditionally been the recom- inoculated onto a brain heart infusion agar plate
mended chemotherapy for most infections in- (Difco) supplemented with 0.5% yeast extract
volving BPB. However, a number of recent (Difco), 1% IsoVitaleX (BBL Microbiology Sysstudies have suggested an increasing.resistance tems, Cockeysville, Md.), 0.5 p.g of vitamin K
of these organisms to penicillin and to other (Sigma Chemical Co., St. Louis, Mo.) per ml,
commonly prescribed antibiotics (1, 2, 5, 6, 8, 0.5 ,ug of hemin (Sigma) per ml, and 5% laked
10). Although this has aroused concern among sheep blood (GIBCO Diagnostics, Madison,
dental clinicians, it cannot be determined from Wis.). The plates were incubated anaerobically
these studies whether BPB present as part of the at 35 to 37°C for 5 to 7 days with the GasPak
normal oral microflora show similar patterns of System (BBL). Colonies that produced brown to
increasing resistance. These studies were con- black pigmentation were subcultured to two
ducted in hospital laboratories and evaluated supplemented brain heart infusion agar plates.
antibiotic susceptibilities of BPB isolates origi- One was incubated anaerobically, and the other
nating from a variety of unspecified body sites was incubated aerobically in an atmosphere of 5
and clinical specimens. Only the study of Nie- to 10o C02. Isolates were identified as members
derau et al. (8) included oral isolates, but the of the B. melaninogenicus-B. asaccharolyticus
number of isolates tested was small (n = 10).
group if they produced a brown to black pigment
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on the anaerobic plate, were incapable of growth
on the aerobic plate, appeared as gram-negative
bacilli or coccobacilli upon staining, and showed
a positive immunofluorescent reaction with the

Fluoretec-M kit (General Diagnostics, WarnerLambert Co., Morris Plains, N.J.). Previous
studies have shown that the Fluoretec-M kit is a
reliable method for identifying B. melaninogenicus and B. asaccharolyticus (12).
The following antibiotics were used in testing:
erythromycin, cephalexin, and potassium penicillin G (Eli Lilly & Co., Indianapolis, Ind.);
clindamycin hydrochloride (The Upjohn Co.,
Kalamazoo, Mich.); tetracycline hydrochloride
and chloramphenicol (Sigma); and ampicillin
(Bristol Laboratories, Syracuse, N.Y.). Appropriate stock solutions of each antibiotic were
prepared in sterile water and stored at -20°C for
not more than 1 week before use.
Antibiotic susceptibility testing was performed according to the National Committee for
Clinical Laboratory Standards proposed standard agar dilution procedure (7). Anaerobic and
aerobic growth control plates without antibiotic
were included in each experiment. Due to the
fastidious nature of the BPB, we found it necessary to add rabbit serum (GIBCO Laboratories,
Grand Island, N.Y.) to a 5% concentration to
the thioglycollate medium and to Wilkins Chalgren agar (Difco). Preliminary experiments
showed that this enhanced the growth and recovery of BPB without changing the acceptable
range of minimal inhibitory concentration (MIC)
values required for the control cultures.
The Wilkins Chalgren agar plates were incubated anaerobically at 35 to 37°C for 48 h. The
MIC for each isolate was defined as the lowest
concentration of antibiotic yielding no growth or
a barely visible haze of growth.
The 1-lactamase test was performed on 41
isolates according to the rapid iodometric method (11). Known positive and negative control
strains were assayed simultaneously. This method was chosen instead of the chromogenic cephalosporin method since 1-lactamases of BPB are
more active against penicillin than against cephalothin (9).
The results of the agar dilution susceptibility
tests are shown in Table 1. The MIC values of
chloramphenicol, cindamycin, penicillin G, and
tetracycline for control cultures of Clostridium
perfringens (ATCC 13124) and Bacteroides thetaiotaomicron (ATCC 29741) fell within the acceptable range (mode MIC + one dilution). MIC
values of the other antibiotics tested have not
been established for the control strains in the
proposed standard.
We found that 90%o of our BPB isolates were
inhibited by penicillin G at 0.5 U/ml or ampicillin
at 0.5 p,g/ml. The six isolates which had penicil-
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TABLE 1. Inhibitory activity of antibiotics against
oral isolates of BPB
MIC (,ug/ml)°
Antibiotic

Penicillin G

Rmgeb
Range

For 50%
inhibition

For 90%o
inhibition

<0.125-8
<0.125
0.5
<0.125-4
<0.125
0.5
<0.125-16 <0.125
4
<0.125-16
0.25
0.5
'0.125-1
<0.125
0.25
<0.125
0.125 <0.125
0.5-2
1
1
G MICs are expressed as units per

Ampicillin
Tetracycline
Cephalexin
Erythromycin
Clindamycin
Chloramphenicol

a Penicillin
milliliter.
b Number of isolates (n) = 66 for all antibiotics
except clindamycin, for which n = 52.

lin MIC values of >0.5 U/ml also had ampicillin
MIC values of >0.5 ,ug/ml. In contrast, recent
studies of isolates of unspecified, presumably
nonoral, origin have found that penicillin and
ampicillin levels from 4 to >64 U or p.g/ml were
required for 90%o inhibition (1, 2, 5, 6, 10; K. E.
Aldridge, C. V. Sanders, and R. L. Marier,
Abstr. Annu. Meet. Am. Soc. Microbiol. 1981,
C21, p. 266). Only the very recent study by
Sutter et al. (V. L. Sutter, M. J. Jones, and
A. T. Ghoneim, Abstr. Annu. Meet. Am. Soc.
Microbiol. 1982, A18, p. 4) reports data similar
to ours. Using isolates from periodontitis patients, Sutter et al. found that 90o of their BPB
isolates were inhibited by penicillin G at 0.5 U/
ml, with a few strains requiring >32 U/ml for
inhibition.
A total of 41 of our isolates were tested for ,lactamase production. These included 37 isolates with penicillin MIC values of c0.5 U/ml
and 4 isolates with penicillin MIC values of 4 to 8
U/ml. All isolates with penicillin MICs of s0.5
U/ml were negative for 1-lactamase, whereas
those with penicillin MICs of 4 to 8 U/ml were
positive. In contrast to Murray and Rosenblatt,
who found 56% of their clinical isolates to be 1Blactamase producing (6), only 10% of our oral
isolates tested exhibited this activity. The clinical significance of this enzyme in anaerobes,
however, is still questionable.
Ninety percent of our isolates were inhibited
by tetracycline at 4 tjg/ml. Studies from 1977 and
1980 reported only 40 to 50% inhibition of BPB
at this concentration (2, 6). We also found that
cephalexin at 0.5 ,ug/ml was sufficient to produce
90%o inhibition. This contrasts greatly with the
report of Niederau at al., who found that cephalexin at 25 ,ug/ml was necessary for 90%o inhibition (8). Additionally, only Niederau et al. have
demonstrated increased resistance to chloramphenicol, finding that 25 ,ug/ml was needed for
90% inhibition. No other studies, including ours,
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have reported increasing resistance to this antibiotic. Likewise, no studies have shown the
BPB to be developing resistance to clindamycin
or erythromycin, regardless of the source or
nature of the specimen.
Our data indicate that oral isolates of BPB are
remaining relatively susceptible to penicillin and
other antibiotics. Other authors have suggested
that their increased isolation of resistant strains
may have been due to extensive antibiotic use at
their hospitals (1, 2). This may account for our
isolation of highly susceptible BPB, since our
isolates were derived from patients who were
not recently hospitalized. Even patients with
endodontic and periodontic infections would be
treated as outpatients. Our patient population
was derived from a broad range of age and
socioeconomic groups; therefore we feel that
resistant strains were not missed as a result of
evaluating a limited or perhaps biased sample.
The increasing isolation rate of antibioticresistant strains from clinical specimens may or
may not foretell an increasing incidence among
the normal oral microflora. Our results suggest
that data generated in clinical laboratories may
not be applicable to endodontic and periodontic
patients or outpatient groups. Periodic monitoring of the susceptibility patterns of oral microorganisms may be appropriate and yield useful
data for the dental clinician and oral surgeon in
the form of a more up-to-date protocol for
therapy.
We thank the following companies for their generous donations of materials used in this study: BBL, Difco, Eli Lilly &
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This work was supported by a grant from the Marquette
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